Table 2.
5MCL-C | 5MCL-N | 5MCL-O | 12MCL-C | 12MCL-O | 34DL-N | 34DL-C1 | 34DL-C2 | 34DL-C3 | 31ML-N1 | 31ML-N2 | 9MLC-O | 15MCL-N | 23ML-N | 20ML-n | 33ML-0 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5MCL-C |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5MCL-N |
0.77 |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5MCL-O |
0.77 |
0.94 |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
12MCL-C |
0.66 |
0.72 |
0.72 |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
|
12MCL-0 |
0.72 |
0.72 |
0.72 |
0.94 |
1.00 |
|
|
|
|
|
|
|
|
|
|
|
34DL-N |
0.69 |
0.58 |
0.58 |
0.69 |
0.69 |
1.00 |
|
|
|
|
|
|
|
|
|
|
34DL-C1 |
0.55 |
0.61 |
0.66 |
0.66 |
0.66 |
0.75 |
1.00 |
|
|
|
|
|
|
|
|
|
34DL-C2 |
0.69 |
0.58 |
0.63 |
0.75 |
0.75 |
0.77 |
0.75 |
1.00 |
|
|
|
|
|
|
|
|
34DL-C3 |
0.72 |
0.72 |
0.72 |
0.66 |
0.66 |
0.69 |
0.77 |
0.75 |
1.00 |
|
|
|
|
|
|
|
31 M1-N1 |
0.66 |
0.72 |
0.72 |
0.77 |
0.77 |
0.63 |
0.66 |
0.63 |
0.66 |
1.00 |
|
|
|
|
|
|
31ML-N2 |
0.50 |
0.55 |
0.50 |
0.55 |
0.61 |
0.58 |
0.55 |
0.52 |
0.50 |
0.55 |
1.00 |
|
|
|
|
|
9MCL-O |
0.72 |
0.66 |
0.66 |
0.77 |
0.83 |
0.69 |
0.55 |
0.75 |
0.61 |
0.72 |
0.66 |
1.00 |
|
|
|
|
15MCL-N |
0.75 |
0.63 |
0.63 |
0.80 |
0.80 |
0.72 |
0.69 |
0.72 |
0.75 |
0.86 |
0.58 |
0.75 |
1.00 |
|
|
|
23ML-N |
0.63 |
0.63 |
0.63 |
0.75 |
0.69 |
0.66 |
0.58 |
0.66 |
0.58 |
0.80 |
0.52 |
0.69 |
0.83 |
1.00 |
|
|
20ML-N |
0.72 |
0.77 |
0.77 |
0.77 |
0.83 |
0.63 |
0.61 |
0.63 |
0.61 |
0.83 |
0.55 |
0.83 |
0.69 |
0.69 |
1.00 |
|
33ML-O | 0.66 | 0.61 | 061 | 0.77 | 0.77 | 0.69 | 0.67 | 0.69 | 0.66 | 0.72 | 0.66 | 0.72 | 0.80 | 0.75 | 0.72 | 1.00 |
MCL mucocustaneous leishmaniasis, DL disseminated leishmaniasis, ML mucosal leishmaniasis, N nasal lesion, O oral lesion, C custaneous lesion, N1 and N2 nasal lesion fragments collected at 2 different times, C1-C3 cutaneous lesion fragments collected at different times.